Qube Research & Technologies (QRT)’s Structure Therapeutics GPCR Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio GPCR Stock Details GPCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.67M	Sell	85,415 -7,988	-9%	-$375K	﹤0.01%	2164
2026 Q2	$5.01M	Buy	93,403 +19,804	+27%	+$876K	﹤0.01%	1627
2026 Q1	$3.55M	Buy	+73,599	New	+$5.04M	﹤0.01%	1838
2024 Q2	–	Sell	-7,165	Closed	-$307K	–	4156
2024 Q1	$307K	Sell	7,165 -33,511	-82%	-$1.41M	﹤0.01%	2796
2023 Q4	$1.66M	Buy	+40,676	New	+$2.33M	﹤0.01%	1632

Other funds holding GPCR

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return

Capitolis Liquid Global Markets New York $22.4B AUM 40.52% 1-Year Est. Return

Pacific Heights Asset Management San Francisco, California $3.1B AUM 37.54% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Qube Research & Technologies (QRT)'s GPCR Position: Q3 2026 in Review

Qube Research & Technologies (QRT) reduced its Structure Therapeutics (GPCR) stake by 8.6% in Q3 2026, selling an estimated $375K and leaving 85,415 shares worth $2.67M. The position accounts for ﹤0.01% of the portfolio, ranked #2164.

Qube Research & Technologies (QRT) first reported a position in GPCR in Q4 2023 and has held it in 5 quarters since. The position peaked at $5.01M in Q2 2026. 113 funds tracked by Wall St. Rank hold GPCR as of Q3 2026.

Qube Research & Technologies (QRT) held 85,415 shares of Structure Therapeutics worth $2.67M as of Q3 2026.
Qube Research & Technologies (QRT) sold 7,988 Structure Therapeutics shares in Q3 2026, an estimated $375K.
Structure Therapeutics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q3 2026, its #2164 holding.
Qube Research & Technologies (QRT) first reported a position in Structure Therapeutics in Q4 2023 and has held it in 5 quarters since.
Qube Research & Technologies (QRT)'s Structure Therapeutics position peaked at $5.01M in Q2 2026.
113 funds tracked by Wall St. Rank held Structure Therapeutics as of Q3 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.